Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $302,955 - $358,742
4,424 New
4,424 $318,000
Q4 2018

Feb 15, 2019

SELL
$48.76 - $63.23 $9,752 - $12,646
-200 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$59.92 - $68.98 $39,427 - $45,388
-658 Reduced 76.69%
200 $13,000
Q4 2017

Feb 08, 2018

BUY
$59.94 - $65.35 $39,440 - $43,000
658 Added 329.0%
858 $53,000
Q2 2017

Aug 14, 2017

BUY
N/A
200
200 $11,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pinkerton Retirement Specialists, LLC Portfolio

Follow Pinkerton Retirement Specialists, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinkerton Retirement Specialists, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pinkerton Retirement Specialists, LLC with notifications on news.